Author

Maliha N Tayeb

Abramson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Kara N. MaxwelliD· 2 shared Ryan M. HausleriD· 2 shared A Dinh Le· 1 shared Abigail G. DoucetteiD· 1 shared Alexandra O. SokolovaiD· 1 shared Anupma NayakiD· 1 shared Arnold J. LevineiD· 1 shared Ashvathi RaghavakaimaliD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Kara N. MaxwellORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicineJournal of the National Comprehensive Cancer NetworkPeer-reviewedJun 2, 2026

Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients

Taylor B. Crawford, Maliha N Tayeb, Emanuel Barrett…·Kara N. Maxwell

This study reports a 5.4% rate of pathogenic germline variants in a racially diverse cohort of prostate cancer patients, with significant associations between PGV rates and age at diagnosis and self-identified race.

DOI 10.6004/jnccn.2026.7006

humanwhole-exome sequencing

𝕏 PostBluesky

GeneticsNature CommunicationsPeer-reviewedMay 21, 2026

Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers

Nabamita Boruah, David Hoyos, Renyta Moses…·Kara N. Maxwell

This study compares genomic and immunologic features of germline TP53-driven breast cancers to sporadic breast cancers, finding distinct patterns of genomic instability and immune infiltration.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky